Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,072Revenue $M1.4Net Margin (%)-2,314.7Z-Score41.5
Enterprise Value $M1,030EPS $-0.3Operating Margin %-3,168.2F-Score3
P/E(ttm))0Cash Flow Per Share $-0.7Pre-tax Margin (%)-2,314.7Higher ROA y-yY
Price/Book28.410-y EBITDA Growth Rate %-13.2Quick Ratio4.1Cash flow > EarningsN
Price/Sales6895-y EBITDA Growth Rate %-0.1Current Ratio4.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-55.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-79.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M115ROI % (ttm)-167.5Gross Margin Increase y-yN

Gurus Latest Trades with ZIOP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZIOPJean-Marie Eveillard 2013-06-30 Sold Out $1.52 - $2.621
($1.85)
$ 9.3580%Sold Out0
ZIOPJean-Marie Eveillard 2013-03-31 Buy $1.72 - $5.71
($4.42)
$ 9.3553%New holding200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZIOP is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ZIOP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KIRK RANDAL JDirector, 10% Owner 2015-02-09Buy1,440,000$8.758.8 view
KIRK RANDAL JDirector, 10% Owner 2013-10-29Buy2,857,143$3.5172 view
KIRK RANDAL JDirector, 10% Owner 2012-01-20Buy1,923,075$5.283.08 view
KIRK RANDAL JDirector, 10% Owner 2011-08-23Buy38,294$4.9990.78 view
KIRK RANDAL JDirector, 10% Owner 2011-08-22Buy461,646$4.9293.5 view
Fowler WycheDirector 2011-08-10Buy5,000$5.1983.43 view
KIRK RANDAL JDirector, 10% Owner 2011-08-09Buy846,522$4.7899.16 view
WEISER MICHAELDirector 2011-05-25Sell15,000$6.5345.79 view
BRENNAN MURRAYDirector 2011-05-09Sell15,000$6.5744.9 view
KIRK RANDAL JDirector, 10% Owner 2011-02-03Buy1,910,000$5.7565.57 view

Press Releases about ZIOP :

    Quarterly/Annual Reports about ZIOP:

    News about ZIOP:

    Articles On GuruFocus.com
    Holdings Mar 31 2015 
    Holdings Mar 31 2015 
    Hayman Advisors Update - Second Quarter Sells and Company Results Aug 26 2013 
    Bass’ New Buy – ZIOPHARM Oncology Inc. May 16 2013 
    The Far-Off Four, 52-week Lows Held by Gurus May 11 2013 
    comment on ZIOP Mar 15 2013 
    cooldecency99 note on ZIOP May 01 2010 
    ZIOPHARM Reports Second Quarter Financial Results and Updates Clinical Programs Aug 14 2009 

    More From Other Websites
    Call buyers come back to Ziopharm Apr 30 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 27 2015
    ZIOPHARM Announces Initiation of Phase 1b/2 Study of Ad-RTS-hIL-12 Gene Therapy in Patients With... Apr 27 2015
    Four one-time biotech underdogs are outperforming the market this year Apr 22 2015
    Ziopharm Oncology (ZIOP) Stock Falls Today on Mediocre Solid Tumor Therapy Data Apr 20 2015
    Big biotech movers: Juno & Kite Apr 20 2015
    Lightning Round: I say this is an opportunity Apr 13 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Apr 02 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 01 2015
    Intrexon-Merck KGaA Team Up for CAR-T Cancer Therapies - Analyst Blog Mar 31 2015
    ZIOPHARM-Intrexon Synthetic Immuno-Oncology Programs Strengthened Through Collaboration With Merck... Mar 30 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Mar 30 2015
    ZIOPHARM-Intrexon Synthetic Immuno-Oncology Programs Strengthened Through Collaboration With Merck... Mar 30 2015
    Three trades to go before the closing bell Mar 20 2015
    Top trades for the 2nd half Mar 20 2015
    Investor sees big rally in Ziopharm Mar 19 2015
    Cramer Remix: Oil news you've been waiting for Mar 18 2015
    ZIOPHARM downgraded by Mizuho Mar 10 2015
    Enter Trades Ahead Of The Emotional Crowd Mar 06 2015
    Cramer Remix: Stocks roaring on execution Mar 05 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK